Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity

This publication has 22 references indexed in Scilit:

• Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis
  Bone Marrow Transplantation, 1998
• Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemia
  British Journal of Haematology, 1997
• Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.
  Journal of Clinical Oncology, 1996
• Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
  Journal of Clinical Oncology, 1996
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995
• Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
  Journal of Clinical Oncology, 1993
• Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.
  Journal of Clinical Oncology, 1992
• GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen
  The Lancet, 1991
• High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.
  Journal of Clinical Oncology, 1990
• Isolation of low-frequency class-switch variants from rat hybrid myelomás
  Journal of Immunological Methods, 1987